Verastem (VSTM) Tops Q2 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. JNJ
3. AAPL
4. META
5. NVDA
6. AMAT
7. NRIX
8. SPY
9. OIG
10. BAC

Go back to Verastem (VSTM) Tops Q2 EPS by 3c

Verastem Reports Second Quarter 2015 Financial and Corporate Results

August 10, 2015 7:00 AM EDT

COMMAND Interim Analysis Anticipated in Third Quarter 2015

BOSTON--(BUSINESS WIRE)-- Verastem, Inc. (NASDAQ: VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today reported financial results for the second quarter ended June 30, 2015, and also provided an overview of certain corporate accomplishments and plans.

Execution of the ongoing COMMAND trial continues to progress well and we remain on track to report the outcome of the interim analysis during the third quarter of 2015, said Robert Forrester, President and Chief Executive Officer of Verastem. The... More